ROCHE HOLDING LTD

CIK 000088913110 companiesBASEL, V8

SEC Profile

Transactions

Companies

Filings

CIK

0000889131

Recent Transactions

20 trades

Sale
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2023-01-25$1.89/sh−75,000→ 4,549,606 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Series A Preferred Stock
2021-11-02−2,495,385→ 0 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2021-11-02+2,495,385→ 2,495,385 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Series B Preferred Stock
2021-11-02−318,140→ 0 total
Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2021-11-02+318,140→ 2,813,525 total
Conversion
Pandion Therapeutics, Inc.
Series A Preferred Stock
2020-07-21−13,138,905→ 0 total
Conversion
Pandion Therapeutics, Inc.
Series B Preferred Stock
2020-07-21−2,414,098→ 0 total
Conversion
Pandion Therapeutics, Inc.
Common Stock
2020-07-21+3,049,973→ 3,049,973 total
Purchase
Pandion Therapeutics, Inc.
Common Stock
2020-07-21$18.00/sh+36,111→ 3,086,084 total
Conversion
Allakos Inc.
Series B Preferrred Stock
2018-07-23−502,632→ 0 total
Conversion
Allakos Inc.
Common Stock
2018-07-23+4,610,723→ 4,610,723 total
Conversion
Allakos Inc.
Series A Preferrred Stock
2018-07-23−4,108,091→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-3 Preferred Stock
2017-07-05−638,194→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series D Preferred Stock
2017-07-05−3,390,885→ 0 total
Purchase
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05$15.00/sh+119,400→ 702,363 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-2 Preferred Stock
2017-07-05−735,775→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series F Preferred Stock
2017-07-05−989,594→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05+579,093→ 582,963 total
Purchase
BIOVERIS CORP
Series B Preferred Stock
2007-06-26+1,000→ 1,000 total
Purchase
BIOVERIS CORP
Common Stock
2007-06-26$21.50/sh+1,000→ 1,000 total

Companies

Recent Filings

Address

GRENZACHERSTRASSE 124

BASEL, V8, CH-4070

View on SEC.gov